Breast cancer incidence, by stage at diagnosis, and mortality in 21 European countries in the era of mammography screening: an international population-based study.

Fiche publication

Date publication

mars 2026

Journal

The Lancet regional health. Europe

Auteurs

Membres identifiés du Cancéropôle Est :
Dr WORONOFF Anne-Sophie

Tous les auteurs :
Cardoso R, Ola I, Jansen L, Hackl M, Ihle P, Francart J, Van Damme N, Valerianova Z, Atanasov T, Májek O, Ngo O, Innos K, Mägi M, Yonli SD, Woronoff AS, Tretarre B, Poncet F, Katalinic A, Walsh PM, Vincerževskienė I, Steponaviciene L, de Munck L, Siesling S, Johannesen TB, Hofvind S, Calisto R, Bento MJ, Alves da Costa F, Mayer A, Lourenço A, Žagar T, Tomšič S, Rodríguez-Barranco M, Sánchez MJ, Lopez de Munain Marques A, Marcos-Gragera R, Sanvisens A, Gil AS, Chirlaque Lopez MD, Galceran J, Saladié F, Sundquist K, Sundquist J, Persson MÅ, Blum M, Mousavi M, von Moos R, Sumkina O, Ryzhov A, Hoffmeister M, Brenner H

Lien Pubmed

https://www.ncbi.nlm.nih.gov/pubmed/41552365

Résumé

Mammography screening programmes have been widely implemented across European countries over the past 40 years with the main aim to detect breast cancer earlier and thereby reduce breast cancer mortality. This study aimed to analyse and compare changes over time in breast cancer incidence, by stage at diagnosis, and breast cancer mortality across countries in relation to the timing of screening implementation and age at diagnosis.